Hyperkalemia: Clinical Trials

13 trials for Hyperkalemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

13 completed. 13 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 413Completed 13

Follow Hyperkalemia: new trials by email Literature Review of Hyperkalemia trials Research Report on Hyperkalemia

Trials (filtered) newest first · largest first

All 13 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
5 Versus 10 Units of Insulin in Hyperkalemia Management
Insulin regular, Dextrose 50, salbutamol - Hyperkalemia, Potassium Imbalance
Phase 4CompletedOman Medical Speciality Board3842023-10-012025-12-22
A Prospective, Randomized, Open-Label, Cross-Over Study of Lokelma to Control Interdialytic Hyperkalemia
LOKELMA 5 GM Powder for Oral Suspension - Hyperkalemia
Phase 4CompletedNephroNet, Inc.882022-04-142024-06-05
Continuing Sodium Zirconium Cyclosilicate (SZC) After Discharge Study
Sodium Zirconium Cyclosilicate (SZC), Local standard of care - Hyperkalaemia, Chronic Kidney Disease
Phase 4CompletedAstraZeneca1862022-03-242025-11-28
Occurrence of Dyskalemia With Treatment for Hypertension
Fixed Dose Combination pill of Telmisartan 40mg and Amlodipine 5 mg - Hypertension, Potassium Imbalance
Phase 4CompletedNational Heart Foundation of Bangladesh10902022-01-152023-07-14
Effects of Patiromer on Pharmacokinetics of Immunosuppresive Drugs in Renal Transplant Recipients
Patiromer Oral Product - Hyperkalemia, Kidney Transplant
Phase 4CompletedOslo University Hospital132021-09-012023-03-23
Study to Assess Efficacy and Safety of SZC for the Management of High Potassium in Patients With Symptomatic HFrEF Receiving Spironolactone
Sodium zirconium cyclosilicate, Placebo, Spironolactone - Hyperkalaemia, Heart Failure With Reduced Ejection Fraction
Phase 4CompletedAstraZeneca3662021-03-082025-07-09
Insulin Dextrose Infusion vs Nebulized Salbutamol vs Combination of Salbutamol and Insulin Dextrose in Acute Hyperkalemia
Salbutamol, Insulin Aspart - Hyperkalemia
Phase 4CompletedNantes University Hospital4192019-12-202026-05-14
Patiromer Efficacy to Reduce Episodic Hyperkalemia in End Stage Renal Disease Patients
Patiromer Oral Powder Product - Hyperkalemia, End Stage Renal Disease
Phase 4CompletedDuke University362019-06-202025-05-30
Use of Patiromer to Transition Chronic Kidney Disease Patients With Hyperkalemia to a Plant-rich Diet.
Patiromer, Research Diet Menu - Chronic Kidney Diseases, Hyperkalemia
Phase 4CompletedNYU Langone Health32018-03-122021-12-01
Pharmacokinetic Study of Tacrolimus and Mycophenolate Mofetil in Kidney Transplant Recipients With Hyperkalemia Receiving Patiromer
Patiromer - Hyperkalemia, Kidney Transplant
Phase 4CompletedThe Rogosin Institute82017-08-012020-04-13
Patiromer With or Without Food for the Treatment of Hyperkalemia
patiromer - Hyperkalemia
Phase 4CompletedRelypsa, Inc.1142016-02-012021-05-12
Efficacy of Sodium Polystyrene Sulfonate in the Treatment of Hyperkaliemia in Pre-dialysis Patients
Sodium polystyrene sulfonate, Lactose with carob gum - Hyperkalemia, Chronic Kidney Failure
Phase 4CompletedMaisonneuve-Rosemont Hospital382014-02-012014-10-03
Spironolactone Versus Spironolactone Plus Furosemide (SVSSF)
Spironolactone and furosemide - Cirrhosis, Ascites
Phase 4CompletedUniversity of Padova1002005-04-012008-09-25

Narrower conditions

Renal Insufficiency, Chronic (3)  ·  Insulin Resistance (2)  ·  Kidney Failure, Chronic (2)  ·  Ascites (1)  ·  Fibrosis (1)  ·  Hypertension (1)  ·  Hypokalemia (1)

Broader conditions

Metabolic Diseases (13)  ·  Nutritional and Metabolic Diseases (13)  ·  Water-Electrolyte Imbalance (13)  ·  Pathologic Processes (6)  ·  Pathological Conditions, Signs and Symptoms (6)  ·  Chronic Disease (5)  ·  Disease Attributes (5)  ·  Female Urogenital Diseases (5)  ·  Female Urogenital Diseases and Pregnancy Complications (5)  ·  Kidney Diseases (5)  ·  Male Urogenital Diseases (5)  ·  Renal Insufficiency (5)  ·  Urogenital Diseases (5)  ·  Urologic Diseases (5)  ·  Glucose Metabolism Disorders (2)

Interventions

patiromer (3)  ·  Albuterol (2)  ·  Insulin (2)  ·  Spironolactone (2)  ·  Suspensions (2)  ·  sodium zirconium cyclosilicate (2)  ·  Amlodipine (1)  ·  Furosemide (1)  ·  Insulin Aspart (1)  ·  Lactose (1)  ·  Telmisartan (1)  ·  polystyrene sulfonic acid (1)

Sponsors

AstraZeneca (2)  ·  Duke University (1)  ·  Maisonneuve-Rosemont Hospital (1)  ·  NYU Langone Health (1)  ·  Nantes University Hospital (1)  ·  National Heart Foundation of Bangladesh (1)  ·  NephroNet, Inc. (1)  ·  Oman Medical Speciality Board (1)  ·  Oslo University Hospital (1)  ·  Relypsa, Inc. (1)  ·  The Rogosin Institute (1)  ·  University of Padova (1)

Countries

United States (6)  ·  Canada (2)  ·  France (2)  ·  Italy (2)  ·  Spain (2)  ·  United Kingdom (2)  ·  Bangladesh (1)  ·  Belgium (1)  ·  Brazil (1)  ·  Czechia (1)  ·  Hungary (1)  ·  Netherlands (1)  ·  Norway (1)  ·  Oman (1)  ·  Poland (1)

Top investigators

David Goldfarb, MD (1)  ·  Fazilatunnesa Malik, MBBS, FCPS (1)  ·  James Tumlin, MD (1)  ·  Jeremy Whitson, BS (1)  ·  John P Middleton, MD (1)  ·  Jun Lee, MD (1)

Results publications

PMID 32588430, PMID 12873814, PMID 19570764, PMID 32847923, PMID 37398685, PMID 38878009, PMID 39566872